Prospective multicentre study of the U-SENS test method for skin sensitization testing.

The U-SENS™ is a test method based on the human myeloid U937 cell line to assess the skin sensitisation potential of substances. To demonstrate its robustness, a multicentre validation study with four laboratories testing 24 coded substances has been conducted according to internationally agreed principles. The primary objective of the study was to enlarge the U-SENS™'s reproducibility database. Secondary objectives were to provide additional evidence on its transferability and its predictive capability. Reproducibility within laboratories was approximately 92%, while the reproducibility between laboratories was 87.5%. Predictivity for the 24 validation substances was high, with sensitivity, specificity and accuracy being on average at least 93.8%. Similar performances are obtained for 38 substances when combining the study results with those of an earlier multicentre study, as well as with an automated version of the U-SENS™. With reliability and relevance similar to comparable non-animal skin sensitisation test methods, which have achieved regulatory acceptance, it is concluded that the U-SENS™ is a well reproducible and predictive test method. This profiles the U-SENS™ as a valuable addition to the suite of non-animal testing methods for skin sensitisation with the potential to significantly contribute to the development of integrated testing strategies.

[1]  A. Agresti,et al.  Comment: Randomized Confidence Intervals and the Mid-P Approach , 2005 .

[2]  Ian Kimber,et al.  Compilation of Historical Local Lymph Node Data for Evaluation of Skin Sensitization Alternative Methods , 2005, Dermatitis : contact, atopic, occupational, drug.

[3]  João Barroso,et al.  Categorization of Chemicals According to Their Relative Human Skin Sensitizing Potency , 2014, Dermatitis : contact, atopic, occupational, drug.

[4]  Aynur Aptula,et al.  Local Lymph Node Data for the Evaluation of Skin Sensitization Alternatives: A Second Compilation , 2010, Dermatitis : contact, atopic, occupational, drug.

[5]  D. Basketter,et al.  The local lymph node assay in 2014. , 2014, Dermatitis : contact, atopic, occupational, drug.

[6]  B. Blömeke,et al.  Sensitization Assays: Monocyte-Derived Dendritic Cells Versus a Monocytic Cell Line (THP-1) , 2008, Journal of toxicology and environmental health. Part A.

[7]  N. Nishiyama,et al.  Development of an in vitro skin sensitization test based on ROS production in THP-1 cells. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[8]  Casati Silvia,et al.  EURL ECVAM Recommendation on the human Cell Line Activation Test (h-CLAT) for skin sensitisation testing , 2015 .

[9]  Yuri Dancik,et al.  Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice , 2013, Journal of applied toxicology : JAT.

[10]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[11]  Givaudan Suisse,et al.  Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing , 2008 .

[12]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[13]  Gilbert Saporta,et al.  Stacking prediction for a binary outcome , 2012 .

[14]  Martina Klaric,et al.  Systematic evaluation of non-animal test methods for skin sensitisation safety assessment. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  Hitoshi Sakaguchi,et al.  Data integration of non-animal tests for the development of a test battery to predict the skin sensitizing potential and potency of chemicals. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  Nathalie Alépée,et al.  The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  Ernesto Estrada,et al.  Computer-aided knowledge generation for understanding skin sensitization mechanisms: the TOPS-MODE approach. , 2003, Chemical research in toxicology.

[18]  Petra S Kern,et al.  Assessing skin sensitization hazard in mice and men using non-animal test methods. , 2015, Regulatory toxicology and pharmacology : RTP.

[19]  David W Roberts,et al.  Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity. , 2006, Chemical research in toxicology.

[20]  Setsuya Aiba,et al.  Skin sensitization risk assessment model using artificial neural network analysis of data from multiple in vitro assays. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[21]  G. Frank Gerberick,et al.  The Local Lymph Node Assay , 2017 .